Citius Oncology Statistics

Total Valuation

CTOR has a market cap or net worth of $151.20 million.

Market Cap	151.20M
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

CTOR has 75.60 million shares outstanding. The number of shares has increased by 100.00% in one year.

Shares Outstanding	75.60M
Shares Change (YoY)	+100.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.97M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.80
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.32

Current Ratio	0.32
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CTOR has paid $576,000 in taxes.

Income Tax	576,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -81.26% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-81.26%
50-Day Moving Average	14.03
200-Day Moving Average	11.78
Relative Strength Index (RSI)	33.20
Average Volume (20 Days)	393,030

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-16.90M
Pretax Income	n/a
Net Income	-17.48M
EBITDA	n/a
EBIT	-16.90M
Earnings Per Share (EPS)	-$0.26

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	19.85M
Book Value Per Share	0.29
Working Capital	-18.71M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTOR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-100.00%
Shareholder Yield	-100.00%
Earnings Yield	-11.56%
FCF Yield	n/a

Analyst Forecast

The average price target for CTOR is $6.00, which is 200.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.00
Price Target Difference	200.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a